Enhancement of solubility and dissolution of Coenzyme Q10 using solid dispersion formulation

International Journal of Pharmaceutics

Volumn 383, Issue 1-2, 2010, Pages 147-153

  Nepal, Pushp R ^a   Han, Hyo Kyung ^a   Choi, Hoo Kyun ^a  

^a Chosun University   (South Korea)

Author keywords

Aerosil 200; Coenzyme Q10; Melting method; Poloxamer 407; Solid dispersion

Indexed keywords

ADSORBENT; AEROSIL; CREMOPHOR; DRUG CARRIER; POLOXAMER; POVIDONE; SILICON DIOXIDE; SOLUTOL HS 15; UBIDECARENONE;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CRYSTALLIZATION; DISPERSION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; PRIORITY JOURNAL;

CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; ENZYME STABILITY; MICROSCOPY, ELECTRON, SCANNING; POLOXAMER; SOLUBILITY; UBIQUINONE;

EID: 70449536477     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.09.031     Document Type: Article

References (31)

1. Aungst B.J. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J. Pharm. Sci. 82 (1993) 979-987
2. 10 binary solid dispersions for enhanced solubility and dissolution. Biol. Pharm. Bull. 30 (2007) 1171-1176
3. Carli F., Chiellini E.E., Bellich B., Macchiavelli S., and Cadelli G. Ubidecarenone nanoemulsified composite systems. Int. J. Pharm. 291 (2005) 113-118
4. Chauhan B., Shimpi S., and Paradkar A. Preparation and evaluation of glibenclamide polyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique. Eur. J. Pharm. Sci. 26 (2005) 219-230
5. Chiou W.L., and Riegelman S. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 60 (1971) 1281-1302
6. Collett J.H., and Popli H. Poloxamer. In: Kibbe A.H. (Ed). Handbook of Pharmaceutical Excipients. 3rd edition (2000), Pharmaceutical Press, London 386-388
7. Craig D.Q.M. The mechanism of drug release from solid dispersion in water-soluble polymers. Int. J. Pharm. 231 (2002) 131-144
8. Dai W.G., Dong L.C., Li S., and Deng Z. Combination of pluronic/vitamin E TPGS as a potential inhibitor of drug precipitation. Int. J. Pharm. 355 (2008) 31-37
9. Dixit R.P., and Nagarsenker M.S. Self-nanoemulsifying granules of ezetimibe: design, optimization and evaluation. Eur. J. Pharm. Sci. 35 (2008) 183-192
10. 10: a new drug for cardiovascular disease. J. Clin. Pharmacol. 30 (1990) 590-608
11. 10 in plasma. J. Chromatogr. 593 (1992) 217-226
12. 10 formulations. Int. J. Pharm. 363 (2008) 112-117
13. 10 from binary solid dispersions using poloxamer 407. AAPS J. 9 S2 (2007)
14. Kim E.J., Chun M.K., Jang J.S., Lee I.H., Lee K.R., and Choi H.K. Preparation of a solid dispersion of felodipine using a solvent wetting method. Eur. J. Pharm. Biopharm. 64 (2006) 200-205
15. Kommuru T.R., Gurley B., Khan M.A., and Reddy I.K. Self-emulsifying drug delivery systems (SEDDS) of Coenzyme Q10: formulation development and bioavailability assessment. Int. J. Pharm. 212 (2001) 233-246
16. Lee K.R., Kim E.J., Seo S.W., and Choi H.K. Effect of poloxamer on the dissolution of felodipine and preparation of controlled release matrix tablets containing felodipine. Arch. Pharm. Res. 31 (2008) 1023-1028
17. Leuner C., and Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50 (2000) 131-144
18. Morefield E. Colloidal silicon dioxide. In: Kibbe A.H. (Ed). Handbook of Pharmaceutical Excipients. 3rd edition (2000), Pharmaceutical Press, London 143-145
19. ® solid dispersion. Drug Dev. Ind. Pharm. 28 (2002) 49-57
20. Nazzal S., Smalyukh I.I., Lavrentovich O.D., and Khan M.A. Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int. J. Pharm. 235 (2002) 247-265
21. Passerini N., Gonzalez-Rodriguez M.L., Cavallari C., Rodriguez L., and Albertini B. Preparation and characterization of ibuprofen-poloxamer 188 granules obtained by melt granulation. Eur. J. Pharm. Sci. 15 (2002) 71-78
22. Pozzi, F., Longo, A., Carenzi, A., 1989. Pharmaceutical composition containing ubidecarenone. U.S. patent number 4,869,900, 26 Sep.
23. Raudonus J., Bernard J., Janben H., Kowalczyk J., and Carle R. Effect of oligomeric or polymeric additive on glass transition, viscosity and crystallization of amorphous isomalt. Food Res. Int. 33 (2000) 41-51
24. Robinson J.R. Introduction: semi-solid formulations for oral drug delivery. Bull. Tech. Gattefosse 89 (1996) 11-13
25. Rosenberg, J., Breitenbach, J., 2004. Stable dosage forms containing Ubiquinones. U.S. Patent Publication no. 2004/0014817 A1.
26. 10 as a migraine preventive. Cephalalgia 22 (2002) 137-141
27. 10 in rats. Asian Pacific J. Cancer Prev. 7 (2006) 599-603
28. Seo A., Holm P., Kristensen H.G., and Schaefer T. The preparation of agglomerates containing solid dispersions of diazepam by melt agglomeration in a high shear mixer. Int. J. Pharm. 259 (2003) 161-171
29. Serajuddin A.T.M. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 88 (1999) 1058-1066
30. Taylor L.S., and Zografi G. Spectroscopic characterization interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res. 14 (1997) 1691-1698
31. 10 by complexation with γ-cyclodextrin in healthy adults. Nutr. Res. 26 (2006) 503-508